Client News

SMX’s (NASDAQ:SMX) Molecular-Level Cybersecurity Solutions Are Critical Upgrades to a $300 Billion Market Needing Supply Chain and Operational Resiliency

MIAMI, FLORIDA / ACCESS Newswire / January 29, 2025 / Cyberattacks are one of the most pressing threats to global stability, disrupting not just industries but entire economies. From the Stuxnet malware to the infamous Colonial Pipeline attack, cyber incidents have targeted critical infrastructure and operational technologies (OT), showcasing their devastating physical and financial consequences. These breaches highlight […]

NanoViricides (NYSE American:NNVC) to Present at the MicroCap Conference on Wednesday, January 29, 2025

SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ. Event Information: Event NanoViricides Presentation at the MicroCap Conference, […]

Rezolve Ai (NASDAQ: RZLV) Defies the AI Cost Spiral with brainpowa LLM – Smarter, Leaner, and Built for Retail Success – Pioneering DeepSeek’s Approach Years Ahead

Delivering high-performance AI without the ‘black hole of capital’ required by traditional LLMs, showing that smarter, leaner models can drive better Ai outcomes NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in AI-driven retail innovation, proudly announces that its groundbreaking large language model, brainpowa, has been engineered from the very […]

NanoViricides (NYSE American:NNVC) Engages CRO for Phase II Clinical Trial

SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline. “NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment […]

Inspire Veterinary Partners (Nasdaq:IVP) Announces 1-for-25 Reverse Stock Split

VIRGINIA BEACH, VA / ACCESS Newswire / January 22, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today announced that it will effect a 1-for-25 reverse stock split (“Reverse Stock Split”) of its authorized and issued and outstanding shares of Class A common […]

Rezolve Ai (NASDAQ: RZLV) Poised to Transform Retail as Stargate’s $500 Billion Investment into AI Supercharges the AI Revolution

President Trump’s announcement of historic investment into AI fuels AI innovation, helping to pave the way for Rezolve Ai’s expansion and leadership in intelligent retail solutions NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a trailblazer in AI-powered retail transformation, celebrates the announcement by President Trump of the creation of Stargate […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.